About

Aims and scope

Lupus Science & Medicine is a global, peer reviewed, Open Access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus.

The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.

Ownership

Lupus Science & Medicine is published by BMJ and owned by the Lupus Foundation of America, which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.

Journal Statistics 2017

Frequency Continuous online publication
Acceptance Rate 46% for original research
Mean time from submission to first decision 29 days
Mean time from acceptance to online publication 13 days
Impact Factor N/A
CiteScore 2.71 (2016)
Indexed by PubMed Central, Scopus, Google Scholar
Launch date 2014
Online ISSN 2053-8790

Contact Information

For all contact information please refer to the contact us page.

For Authors

Please refer to the Instructions for authors

To advertise

Rights and Permissions

Affiliations

Lupus Foundation of America

Lupus Foundation of America

COPE logo

The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator

The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.

Related BMJ sites